(PharmaNewsWire.Com, June 23, 2017 ) Market Data Forecast recently published a report on the North America Next Generation Sequencing Market which estimates the market which was worth $1.33 billion in 2015 and is expected to be growing at a CAGR of 18.6%, to reach $3.11 billion by 2020 during the forecast period from 2015 to 2020.
Next generation sequencing (NGS), massively parallel or deep sequencing are related terms that describe a DNA sequencing technology which has revolutionized genomic research. Using NGS an entire human genome can be sequenced within a single day. In contrast, the previous Sanger sequencing technology, used to decipher the human genome, required over a decade to deliver the final draft. Although in genome research NGS has mostly superseded conventional Sanger sequencing, it has not yet translated into routine clinical practice.
There are a number of different NGS platforms using different sequencing technologies. However, all NGS platforms perform sequencing of millions of small fragments of DNA in parallel. Bioinformatics analyses are used to piece together these fragments by mapping the individual reads to the human reference genome. Each of the three billion bases in the human genome is sequenced multiple times, providing high depth to deliver accurate data and an insight into unexpected DNA variation. NGS can be used to sequence entire genomes or constrained to specific areas of interest, including all 22 000 coding genes (a whole exome) or small numbers of individual genes.
The DROC Analysis contains some of the factors that have major effects on the market dynamics be it positive or negative. Rise in growth of personalized medicine, development in pre-sequencing and NGS bioinformatics solutions and cloud computing, growth in North American population, increasing incidence of infectious diseases and cancer are some of the factors driving the market growth. In addition, anticipated decrease in the prices of genome sequencing due to development of rapid, high capacity whole genome sequencers by key players is expected to show an optimistic effect on the market penetration rates over the few years. However, the storage and management of enormous data generated by sequencing and its interpretation, high reliability on grants & funding from the government and fall in capital expenditure from academic institutions are the key challenges faced by North America next generation sequencing market.
The market is segmented based on product, technology and application and is studied for a deep-level understanding of the Next Generation Sequencing (NGS) market. Each sub segment is accompanied with Market Size Estimations and Y-o-Y Forecasts as well.
Based on geography the market is analysed under various countries namely, USA and Canada. North American region commanded the largest revenue in 2015 due to advanced technological healthcare framework, rise in growth of personalized medicine, increasing incidence of infectious disease and cancer, high R&D investment for genomic and proteomic sequence determination for biomarker and drug discovery research.
Scope of the North America Next Generation Sequencing (NGS)Market:
Regional and country-level analysis that provides an innate perspective of USA and Canada Market to that of the North American region
To detect major focus areas of industrial growth Segment-level analysis on basis of type, therapeutics, end-user along with market size forecasts and y-o-y estimations are provided
Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics
PESTLE and Porters Five Forces Analyses that examine the macro& micro environmental factors such as political influence, technological prowess, industry rivalry to name a few.
An extensive listing of major market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and analyst overview to study and sustain the market environment
mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies all rolled out into Competitive landscape
Expertly devised Market Outlook comprising the Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Biotechnology Segment:
The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the clients research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
